Navigation Links
Cytopia Commences Phase II Cancer Drug Study

$3 billion by 2013.

Cytopia is also currently conducting a Phase I study investigating the safety and tolerability of CYT997 following oral administration. The company also intends to file regulatory applications in support of other Phase II studies over the coming months.

The following table provides a summary of the key aspects of the Phase II multiple myeloma trial.

Name of trial A prospective, single-arm, two-stage, open-label

Phase II trial of CYT997 in relapsed and

refractory multiple myeloma (CCL07001)

Primary endpoints Determination of the overall response rate to CYT997

Secondary endpoints Time to progression; number of cycles of CYT997 to

achieve maximum response; overall survival and

safety and tolerability

Blinding status Not blinded

Product development Drug substance and drug product are manufactured to

status GMP standards

Treatment method

Route 24 hour intravenous infusion dose

Frequency Days 1 and 8 of a 21 day cycle

Dose-levels 202 mg/m2 CYT997 dihydrochloride

Number of trial 24 patients maximum


Subject selection Eligible patients must have a diagnosis of

criteria multiple myeloma (per World Health Organisation

criteria) and have received at least one but no

more than three previous lines of therapy

Trial location Melbourne, Australia

Expected completion Interim analysis (14 patients) Q3, 2008

Trial standard ICH-GCP

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer. Cytopia conducts its research and development via subsidiaries based in

SOURCE Cytopia Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Exelixis Commences Public Offering of Common Stock
3. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
4. American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program
5. Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program
6. Ovation further advances development pipeline with new phase III epilepsy study
7. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
8. Mannatech Launches Phase One of New Sales and Training Tools
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Manic phase of bipolar disorder benefits from breast cancer medication
11. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
Post Your Comments:
(Date:10/20/2014)... (PRWEB) October 20, 2014 ASCNYC ... organization that helps New Yorkers living with HIV/AIDS ... toward health, housing, recovery and self-sufficiency. Each year, ... the local community through their tireless efforts. , ... Marc Shapses , has been selected as this ...
(Date:10/20/2014)... ATLANTA, Ga. (PRWEB) October 20, 2014 ... networking and relationship-marketing firm, announced today that William ... been named the 2014 ISE® Luminary Leadership Award ... celebrates the achievements of an outstanding leader and ... stewardship and contributions in advancing the information security ...
(Date:10/20/2014)... D.C. (PRWEB) October 20, 2014 Zereana Jess-Huff, ... crowned Mrs. Maryland 2014 on a platform to think outside ... scars, and uses her position to raise awareness about women’s ... awareness for breast cancer. You say the color pink and ... I know for a fact that it has not been ...
(Date:10/20/2014)... My Clients Plus ( ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... CA (PRWEB) October 20, 2014, a ... the latest information from the FDA on Sit and ... October 10 not to purchase or use Sit and Slim ... and Slim II is promoted as weight loss product on ... removed from the market in 2010 for safety reasons, can ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2
... time. A new research study, led by a ... shows that worrying can be so intrusive and obsessive ... the health of social relationships. These people suffer ... Western Reserve psychologist Amy Przeworski. Individuals with ...
... of war for returning veterans may include addictions, injury ... Now a University of Houston joint study funded ... service looks to address these issues through the use ... of Social Work (GCSW) joins Baylor College of Medicine ...
... , TUESDAY, July 26 (HealthDay News) -- Prevention is the ... the United States, which reached $450 billion last year, according ... (AHA). Programs to better manage cholesterol, blood pressure and ... nation,s health and economy, said the heart experts as they ...
... An ophthalmologist at UT Southwestern Medical Center has helped ... degenerative eye disease better track vision changes. With the ... accurate self-test in less than 90 seconds, said Dr. Yu-Guang ... "Many patients do not have timely eye exams and end ...
... , TUESDAY, July 26 (HealthDay News) -- A person,s ... to walk in other people,s shoes, no matter how different ... the University of Southern California found people automatically attempt to ... To do that, however, people must use two separate regions ...
... A new study has found that patients with ... in the thalamus, a centrally located relay station for ... study appear online in the journal Radiology . ... connectivity of thalamocortical networks in patients following MTBI, due ...
Cached Medicine News:Health News:Worrying can impact interpersonal relationships, study finds 2Health News:Returning vets' alcohol abuse addressed in virtual reality study 2Health News:Heart Disease Prevention May Save Billions Annually in U.S. 2Health News:UT Southwestern ophthalmologist helps develop device for monitoring degenerative eye disease 2Health News:Human Brains Wired to Empathize, Study Finds 2Health News:Brain connectivity disrupted in patients with post-concussive syndrome 2
(Date:10/19/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... the Board of Directors of his decision to step down from ... of Severn Trent plc.  James will leave Shire at the end ... a new CFO immediately. Flemming Ornskov, Shire,s Chief Executive ... high-quality finance team at Shire. We are very grateful to him ...
(Date:10/17/2014)... Oct. 17, 2014 With the recent ... function has come across several challenges in creating ... managing globalization.  The Medical ... dedicated to providing benchmarking and best practices across ... is a service composed of three stages: 1) ...
(Date:10/17/2014)... Research ... addition of the  "China Interventional Cardiovascular Device ...      (Logo: The ... China impacted by accelerated aging ... dietary habit, way of working and other ...
Breaking Medicine Technology:Interim Chief Financial Officer James Bowling to Step Down 2Interim Chief Financial Officer James Bowling to Step Down 3Interim Chief Financial Officer James Bowling to Step Down 4Early Key Findings from the Medical Affairs Consortium Research 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3
... The oncology therapeutic area continues to be an ... as next generation oncology therapies find success in a ... success, organizations in the oncology therapeutic area are facing ... the factors that play the biggest role in the ...
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... second quarter financial results at 5:00 pm Eastern (2:00 ... President and Chief Executive Officer, and Peter McAree, Chief ... operational and financial results and the company,s outlook for ...
Cached Medicine Technology:Success Factors and Failure Points for Oncology New Product Launches 2Caliper Life Sciences' Second Quarter Results Conference Call Notice 2
... of guiding introducers includes Swartz™ Series, ... piece steerable, all designed for the ... varying curves and longer sheath lengths ... Jude Medical guiding introducers are designed ...
Lumenis 1000 Integrated Slit Lamp Fully-integrated biomicroscope slit lamp laser delivery system, complete with built-in LaserLink, parallel optics, magnification changer, micromanipulator and multi...
Novus 30001 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
... Selecta Trio The pinnacle ... Nd:YAG, diode-pumped solid-state (DPSS) 532 ... laser (SLT) and offering maximum ... The first and only Nd:YAG, ...
Medicine Products: